Europe End Stage Renal Disease Market Size & Outlook
- MedTech
- Nephrology Devices
- End Stage Renal Disease Market Outlook
- Nephrology Devices
Europe End Stage Renal Disease Market, 2018-2030 (US$M)
Global Market
Related Markets
Ask a question about the end stage renal disease market
Europe end stage renal disease market highlights
- The Europe end stage renal disease market generated a revenue of USD 11,589.9 million in 2023.
- The market is expected to grow at a CAGR of 12.1% from 2024 to 2030.
- In terms of segment, dialysis was the largest revenue generating treatment type in 2023.
- Dialysis is the most lucrative treatment type segment registering the fastest growth during the forecast period.
- Country-wise, France is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 11,589.9 million |
| Market revenue in 2030 | USD 25,750.1 million |
| Growth rate | 12.1% (CAGR from 2023 to 2030) |
| Largest segment | Dialysis |
| Fastest growing segment | Dialysis |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Transplant, Dialysis |
| Key market players worldwide | Nipro Corp, Fresenius SE & Co KGaA, Baxter International Inc, Medtronic PLC, B. Braun, BD, Asahi Kasei Corp, Cantel Medical, Nikkiso Co Ltd, JMS Support Japan |
Other key industry trends
- In terms of revenue, Europe region accounted for 10.4% of the global end stage renal disease market in 2023.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 99,670.3 million by 2030.
The region is further segmented into the UK and Germany, France, Italy and Span, wherein Germany is anticipated to witness growth at a CAGR of 11.2% owing to the increasing funding and growing number of dialysis centers.
As per a study published in Clinical Kidney Journal, the incidence rate of Renal Replacement Therapy (RRT) for end stage renal disease was around 121 per million population.
Furthermore, presence of major key players, such as Baxter, is expected to propel the entry of new products at a faster pace within the region.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
End Stage Renal Disease Market Scope
End Stage Renal Disease Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Baxter International Inc | View profile | 60,000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | www.baxter.com |
| Medtronic PLC | View profile | 95,000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | www.medtronic.com |
| Fresenius SE & Co KGaA | View profile | 193,865 | Else-Kroener-Strasse 1, Bad Homburg, HE, Germany, 61352 | www.fresenius.com |
| Asahi Kasei Corp | View profile | 48,897 | 1-105 Kanda Jinbocho, Chiyoda-ku, Tokyo, Japan, 101-8101 | www.asahi-kasei.co.jp |
| B. Braun | View profile | 10001+ | Chapeltown, Sheffield, United Kingdom, Europe | www.bbraun.co.uk |
| Nipro Corp | View profile | 39,713 | 3-9-3 Honjo-Nishi Kita-ku, Osaka, Japan, 531-8510 | www.nipro.co.jp |
| Nikkiso Co Ltd | View profile | 8,529 | 4-20-3, Ebisu, Shibuya-ku, Tokyo, Japan, 150-6022 | www.nikkiso.co.jp |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | www.bd.com |
| Cantel Medical | View profile | 1001-5000 | Little Falls, New Jersey, United States, North America | www.cantelmedical.com |
| JMS Support Japan | View profile | 11-50 | Tokyo, Tokyo, Japan, Asia | jms-support.jp |
Europe End Stage Renal Disease Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to End Stage Renal Disease Market Outlook will help companies and investors design strategic landscapes.
Dialysis was the largest segment with a revenue share of 78.13% in 2023.
Horizon Databook has segmented the Europe end stage renal disease market based on transplant, dialysis covering the revenue growth of each sub-segment from 2018 to 2030.
The region is further segmented into the UK and Germany, France, Italy and Span, wherein Germany is anticipated to witness growth at a CAGR of 11.2% owing to the increasing funding and growing number of dialysis centers.
As per a study published in Clinical Kidney Journal, the incidence rate of Renal Replacement Therapy (RRT) for end stage renal disease was around 121 per million population.
Furthermore, presence of major key players, such as Baxter, is expected to propel the entry of new products at a faster pace within the region.
- Europe End Stage Renal Disease Market Treatment Type Outlook (Revenue, USD Million , 2018-2030)
- Transplant
- Dialysis
Reasons to subscribe to End Stage Renal Disease Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of End Stage Renal Disease Market Outlook databook
- Our clientele includes a mix of End Stage Renal Disease Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe End Stage Renal Disease Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe End Stage Renal Disease Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Europe End Stage Renal Disease Market, 2018-2030 (US$M)
Europe end stage renal disease market statistics, by treatment type, 2018-2030 (US$M)
